Ann M Dennis1, Sonia Napravnik, Arlene C Seña, Joseph J Eron. 1. Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7030, USA. adennis@med.unc.edu
Abstract
BACKGROUND: Late diagnosis of human immunodeficiency virus (HIV) infection remains common despite advances in therapy and prognosis. The southeastern United States is a rapidly growing Latino settlement area where ethnic disparities may contribute to late presentation to care. METHODS: We assessed demographic and clinical factors between racial/ethnic groups at the time of HIV care initiation in the University of North Carolina Center for AIDS Research Clinical Cohort. We identified independent predictors of late presentation, defined as a CD4(+) T lymphocyte (CD4) count <350 cells/mm(3) or an AIDS-defining event (ADE), using log-linear binomial regression. RESULTS: During the period 1999-2009, 853 patients initiated HIV care, of whom 11% were Latino, 28% were white, and 61% were black. Median initial CD4 counts were lower for Latino patients (186 cells/mm(3)) than white patients (292 cells/mm(3); P = .006) and black patients (302 cells/mm(3); P = .02). Latino persons were more likely to be late presenters than white or black persons (76% vs 58%; P < .001) and accounted for 86%, 75%, and 50% of all presenting cases of active tuberculosis, histoplasmosis, and toxoplasmosis, respectively. Latino ethnicity, older age, male sex, and earlier entry year were independently associated with late presentation (P < .05 for all). In multivariable analyses, Latino persons were 1.29 times more likely to present to care late than white or black persons (95% confidence interval, 1.15-1.45). CONCLUSIONS: Latinos are more likely to initiate HIV care later in the course of illness than are black and white persons and account for a majority of several ADEs. Strategies to improve earlier HIV testing among Latinos in new settlement areas are needed.
BACKGROUND: Late diagnosis of human immunodeficiency virus (HIV) infection remains common despite advances in therapy and prognosis. The southeastern United States is a rapidly growing Latino settlement area where ethnic disparities may contribute to late presentation to care. METHODS: We assessed demographic and clinical factors between racial/ethnic groups at the time of HIV care initiation in the University of North Carolina Center for AIDS Research Clinical Cohort. We identified independent predictors of late presentation, defined as a CD4(+) T lymphocyte (CD4) count <350 cells/mm(3) or an AIDS-defining event (ADE), using log-linear binomial regression. RESULTS: During the period 1999-2009, 853 patients initiated HIV care, of whom 11% were Latino, 28% were white, and 61% were black. Median initial CD4 counts were lower for Latino patients (186 cells/mm(3)) than white patients (292 cells/mm(3); P = .006) and black patients (302 cells/mm(3); P = .02). Latino persons were more likely to be late presenters than white or black persons (76% vs 58%; P < .001) and accounted for 86%, 75%, and 50% of all presenting cases of active tuberculosis, histoplasmosis, and toxoplasmosis, respectively. Latino ethnicity, older age, male sex, and earlier entry year were independently associated with late presentation (P < .05 for all). In multivariable analyses, Latino persons were 1.29 times more likely to present to care late than white or black persons (95% confidence interval, 1.15-1.45). CONCLUSIONS: Latinos are more likely to initiate HIV care later in the course of illness than are black and white persons and account for a majority of several ADEs. Strategies to improve earlier HIV testing among Latinos in new settlement areas are needed.
Authors: Biru Yang; Shirley K Chan; Naqi Mohammad; Jeffrey A Meyer; Jan Risser; Karen J Chronister; Marcia L Wolverton; Raouf R Arafat; Lu-Yu Hwang Journal: AIDS Care Date: 2010-06
Authors: Keri N Althoff; Stephen J Gange; Marina B Klein; John T Brooks; Robert S Hogg; Ronald J Bosch; Michael A Horberg; Michael S Saag; Mari M Kitahata; Amy C Justice; Kelly A Gebo; Joseph J Eron; Sean B Rourke; M John Gill; Benigno Rodriguez; Timothy R Sterling; Liviana M Calzavara; Steven G Deeks; Jeffrey N Martin; Anita R Rachlis; Sonia Napravnik; Lisa P Jacobson; Gregory D Kirk; Ann C Collier; Constance A Benson; Michael J Silverberg; Margot Kushel; James J Goedert; Rosemary G McKaig; Stephen E Van Rompaey; Jinbing Zhang; Richard D Moore Journal: Clin Infect Dis Date: 2010-06-01 Impact factor: 9.079
Authors: Cyrille Delpierre; Rosemary Dray-Spira; Lise Cuzin; Bruno Marchou; Patrice Massip; Thierry Lang; France Lert Journal: Int J STD AIDS Date: 2007-05 Impact factor: 1.359
Authors: Hélène Carabin; Marguerite S Keesee; Linda J Machado; Timothy Brittingham; Lynda Williams; Nancy K Sonleitner; Kermyt G Anderson; Adan Cajina; Morris W Foster Journal: AIDS Patient Care STDS Date: 2008-11 Impact factor: 5.078
Authors: Brettania L W Lopes; Joseph J Eron; Michael J Mugavero; William C Miller; Sonia Napravnik Journal: J Acquir Immune Defic Syndr Date: 2017-10-01 Impact factor: 3.731
Authors: Lisa R Metsch; Daniel J Feaster; Lauren Gooden; Tim Matheson; Maxine Stitzer; Moupali Das; Mamta K Jain; Allan E Rodriguez; Wendy S Armstrong; Gregory M Lucas; Ank E Nijhawan; Mari-Lynn Drainoni; Patricia Herrera; Pamela Vergara-Rodriguez; Jeffrey M Jacobson; Michael J Mugavero; Meg Sullivan; Eric S Daar; Deborah K McMahon; David C Ferris; Robert Lindblad; Paul VanVeldhuisen; Neal Oden; Pedro C Castellón; Susan Tross; Louise F Haynes; Antoine Douaihy; James L Sorensen; David S Metzger; Raul N Mandler; Grant N Colfax; Carlos del Rio Journal: JAMA Date: 2016-07-12 Impact factor: 56.272